Intellipharmaceutics International Inc. (IPCI)

[WeeZuhl]

Sorry Fred, Rexista likely has similar problems

The FDA is removing Endo's opioid Opano ER from the market. It will be interesting to see the reasons and fallout from that for IPCI. It should be positive given Rexista is a solution for Opano's problems, but the market is weird, so you can't be sure.

Since both drugs use PEO as ADF formula, Rexista is much more likely to have the same problems as Opana than to provide a solution. Pesky facts.